PHARMACIE PASTEUR: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
PHARMACIE PASTEUR
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€8,993
2024 · €20,378-€11,385
Equity
€262,430
2024 · €262,627-€197
Cash
€40,280
2024 · €35,029+€5,251
Balance sheet total
€729,636
2024 · €589,251+€140,385
Largest movements
Assets
- Tangible fixed assets +€99,027
up €99,027 (+62.6%), from €158,088 to €257,115
of which Land and buildings: +€62,613
- Stocks and contracts +€40,255
up €40,255 (+23.0%), from €175,074 to €215,329
Equity and liabilities
- Debts after one year +€99,977
up €99,977 (+253%), from €39,509 to €139,486
- Other debts +€20,062
up €20,062 (+14.3%), from €140,449 to €160,511
- Trade debts +€15,235
up €15,235 (+16.1%), from €94,599 to €109,834
Income statement
- Gross operating margin +€32,868
up €32,868 (+14.7%), from €222,837 to €255,705
- Staff costs +€29,180
up €29,180 (+20.0%), from €145,839 to €175,020
- Depreciation +€12,345
up €12,345 (+51.7%), from €23,897 to €36,242
- Other operating charges +€6,076
up €6,076 (+93.1%), from €6,525 to €12,601
- Taxes -€2,700
down €2,700 (-44.5%), from €6,072 to €3,373
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€20,378
Gross operating margin
+€32,868
Staff costs
-€29,180
Depreciation
-€12,345
Other operating charges
-€6,076
Financial income
-€6
Financial charges
+€655
Taxes
+€2,700
Result 2025
€8,993
raises the resultlowers the result
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€48,988
Investment
-€134,269
Financing
+€90,533
Cash 2024
€35,029
From operations (derived)
+€48,988
Net result for the year
+€8,993
Depreciation
+€36,242
Stocks and contracts
-€40,255
Receivables within one year
+€5,125
Deferred charges and accrued income
-€1,977
Trade debts
+€15,235
Tax, wage and social debts
+€5,307
Other debts
+€20,062
Accrued charges and deferred income
+€256
Investment (derived)
-€134,269
Investment in fixed assets (net)
-€134,269
Financing
+€90,533
Debts after one year
+€99,977
Current portion of long-term debt
-€254
Contributions, distributions and other
-€9,190
Cash 2025
€40,280
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €589,251 | €729,636 | +€140,385 | +23.8% |
| Fixed assets | 21/28 | €161,753 | €259,780 | +€98,027 | +60.6% |
| Intangible fixed assets | 21 | €3,225 | €2,225 | -€1,000 | -31.0% |
| Tangible fixed assets | 22/27 | €158,088 | €257,115 | +€99,027 | +62.6% |
| Land and buildings | 22 | €34,402 | €97,016 | +€62,613 | +182% |
| Plant, machinery and equipment | 23 | €97,885 | €138,090 | +€40,205 | +41.1% |
| Furniture and vehicles | 24 | €25,801 | €22,009 | -€3,791 | -14.7% |
| Financial fixed assets | 28 | €440 | €440 | = | 0.0% |
| Current assets | 29/58 | €427,498 | €469,856 | +€42,358 | +9.9% |
| Stocks and contracts in progress | 3 | €175,074 | €215,329 | +€40,255 | +23.0% |
| Stocks | 30/36 | €175,074 | €215,329 | +€40,255 | +23.0% |
| Amounts receivable within one year | 40/41 | €117,358 | €112,233 | -€5,125 | -4.4% |
| Trade receivables | 40 | €104,274 | €104,580 | +€306 | +0.3% |
| Other amounts receivable | 41 | €13,085 | €7,653 | -€5,432 | -41.5% |
| Current investments | 50/53 | €96,000 | €96,000 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €35,029 | €40,280 | +€5,251 | +15.0% |
| Deferred charges and accrued income | 490/1 | €4,037 | €6,014 | +€1,977 | +49.0% |
| Total equity and liabilities | 10/49 | €589,251 | €729,636 | +€140,385 | +23.8% |
| Equity | 10/15 | €262,627 | €262,430 | -€197 | -0.1% |
| Contributions | 10/11 | €61,500 | €61,500 | = | 0.0% |
| Capital | 10 | €61,500 | €61,500 | = | 0.0% |
| Issued capital | 100 | €61,500 | €61,500 | = | 0.0% |
| Revaluation surpluses | 12 | €7,822 | €7,822 | = | 0.0% |
| Reserves | 13 | €192,150 | €192,150 | = | 0.0% |
| Non-distributable reserves | 130/1 | €102,150 | €102,150 | = | 0.0% |
| Legal reserve | 130 | €6,150 | €6,150 | = | 0.0% |
| Own shares acquired | 1312 | €96,000 | €96,000 | = | 0.0% |
| Distributable reserves | 133 | €90,000 | €90,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €1,155 | €957 | -€197 | -17.1% |
| Amounts payable | 17/49 | €326,624 | €467,206 | +€140,582 | +43.0% |
| Amounts payable after more than one year | 17 | €39,509 | €139,486 | +€99,977 | +253% |
| Financial debts | 170/4 | €39,509 | €139,486 | +€99,977 | +253% |
| Amounts payable within one year | 42/48 | €286,349 | €326,698 | +€40,349 | +14.1% |
| Current portion of amounts payable after more than one year | 42 | €16,174 | €15,921 | -€254 | -1.6% |
| Trade debts | 44 | €94,599 | €109,834 | +€15,235 | +16.1% |
| Suppliers | 440/4 | €94,599 | €109,834 | +€15,235 | +16.1% |
| Taxes, remuneration and social security | 45 | €35,126 | €40,433 | +€5,307 | +15.1% |
| Taxes | 450/3 | €10,951 | €13,472 | +€2,521 | +23.0% |
| Remuneration and social security | 454/9 | €24,175 | €26,961 | +€2,785 | +11.5% |
| Other amounts payable | 47/48 | €140,449 | €160,511 | +€20,062 | +14.3% |
| Accrued charges and deferred income | 492/3 | €766 | €1,023 | +€256 | +33.5% |
| Remuneration, social security and pensions | 62 | €145,839 | €175,020 | +€29,180 | +20.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €23,897 | €36,242 | +€12,345 | +51.7% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €0 | - | = | |
| Other operating charges | 640/8 | €6,525 | €12,601 | +€6,076 | +93.1% |
| Gross operating margin | 9900 | €222,837 | €255,705 | +€32,868 | +14.7% |
| Operating profit (loss) | 9901 | €46,575 | €31,842 | -€14,733 | -31.6% |
| Financial income | 75/76B | €20 | €14 | -€6 | -30.5% |
| Recurring financial income | 75 | €20 | €14 | -€6 | -30.5% |
| Financial charges | 65/66B | €20,145 | €19,490 | -€655 | -3.3% |
| Recurring financial charges | 65 | €20,145 | €19,490 | -€655 | -3.3% |
| Profit (loss) for the period before taxes | 9903 | €26,450 | €12,366 | -€14,084 | -53.2% |
| Income taxes | 67/77 | €6,072 | €3,373 | -€2,700 | -44.5% |
| Profit (loss) for the period | 9904 | €20,378 | €8,993 | -€11,385 | -55.9% |
| Profit (loss) for the period to be appropriated | 9905 | €20,378 | €8,993 | -€11,385 | -55.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.